Similarly, proto-oncogene PIM1, a member of the PIM family of serine/threonine kinases, was identified from lymphoma samples as a frequently activated gene, which is highly conserved evolutionarily (Zhang H. et al., 2022). The gene discussed is MARK2; the disease is lymphoma.